Overview
Hereditary sensory and autonomic neuropathy (HSAN), also known as hereditary sensory neuropathy (HSN) or hereditary sensory and autonomic neuropathy group, encompasses a clinically and genetically heterogeneous group of rare inherited disorders that primarily affect the peripheral sensory and autonomic nervous systems. These conditions are characterized by progressive degeneration or abnormal development of sensory neurons (particularly small fiber neurons responsible for pain and temperature sensation) and, to varying degrees, autonomic neurons that control involuntary body functions such as sweating, blood pressure regulation, and gastrointestinal motility. HSANs are classified into several subtypes (HSAN types I through VIII and additional forms), each with distinct genetic causes, inheritance patterns, and clinical presentations. Common features across the group include reduced or absent pain and temperature sensation, which can lead to painless injuries, chronic skin ulcers, infections, and in severe cases, acral mutilation and osteomyelitis requiring amputation. Autonomic dysfunction may manifest as anhidrosis (inability to sweat), episodic fevers, postural hypotension, gastrointestinal disturbances, and impaired lacrimation. Some subtypes present at birth or in infancy with severe manifestations including feeding difficulties and failure to thrive, while others have a later onset with predominantly sensory symptoms. There is currently no cure for HSAN. Treatment is supportive and multidisciplinary, focusing on prevention and management of complications. This includes meticulous skin and wound care, protective footwear, regular monitoring for injuries and infections, pain management when neuropathic pain is present, and management of autonomic symptoms. Orthopedic interventions may be necessary for skeletal complications. Genetic counseling is recommended for affected families. Early diagnosis and preventive strategies are essential to minimize tissue damage and improve quality of life.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
7 eventsAstraZeneca — PHASE1
Anwaar Saeed — PHASE1
Saglik Bilimleri Universitesi — NA
Acrivon Therapeutics — PHASE1
Zhuhai Yufan Biotechnologies Co., Ltd — PHASE1, PHASE2
Zhuhai Yufan Biotechnologies Co., Ltd — PHASE1
Restorbio Inc. — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hereditary sensory and autonomic neuropathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary sensory and autonomic neuropathy at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary sensory and autonomic neuropathy.
Community
No community posts yet. Be the first to share your experience with Hereditary sensory and autonomic neuropathy.
Start the conversation →Latest news about Hereditary sensory and autonomic neuropathy
Disease timeline:
New recruiting trial: Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
A new clinical trial is recruiting patients for Hereditary sensory and autonomic neuropathy
New recruiting trial: A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
A new clinical trial is recruiting patients for Hereditary sensory and autonomic neuropathy
New recruiting trial: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
A new clinical trial is recruiting patients for Hereditary sensory and autonomic neuropathy
New recruiting trial: 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
A new clinical trial is recruiting patients for Hereditary sensory and autonomic neuropathy
New recruiting trial: A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
A new clinical trial is recruiting patients for Hereditary sensory and autonomic neuropathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary sensory and autonomic neuropathy
What is Hereditary sensory and autonomic neuropathy?
Hereditary sensory and autonomic neuropathy (HSAN), also known as hereditary sensory neuropathy (HSN) or hereditary sensory and autonomic neuropathy group, encompasses a clinically and genetically heterogeneous group of rare inherited disorders that primarily affect the peripheral sensory and autonomic nervous systems. These conditions are characterized by progressive degeneration or abnormal development of sensory neurons (particularly small fiber neurons responsible for pain and temperature sensation) and, to varying degrees, autonomic neurons that control involuntary body functions such as
Which specialists treat Hereditary sensory and autonomic neuropathy?
3 specialists and care centers treating Hereditary sensory and autonomic neuropathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.